middle.news
Microba Surges 145% in Test Volumes, Eyes FY26 Break-Even
9:28am on Tuesday 28th of October, 2025 AEDT
•
Healthcare
Read Story
Microba Surges 145% in Test Volumes, Eyes FY26 Break-Even
9:28am on Tuesday 28th of October, 2025 AEDT
Key Points
Core test volumes up 145% year-on-year, surpassing 20,000 annualised tests
Growth product revenue up 151%, offsetting sharp decline in legacy products
Operating cash outflows down 16% quarter-on-quarter due to restructuring
Therapeutics R&D ceased; focus shifted to partnerships and clinical trial catalysts
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE